ghk cu injectable dosage human studies GHK-Cu Peptide Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy The Effect of the Human

One clinical study found that using 5% topical vitamin C for six months improved signs of photodamaged skin, both on the surface and in the deeper structural layers of the skin

GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex) is a naturally occurring copper-binding tripeptide first identified in human plasma in 1973

While not a cure for medical conditions, GHK-Cu is being studied for its potential in: Skin aging and photodamage Wound and scar healing Hair loss (alopecia, thinning) Inflammatory skin disorders Post-procedure recovery It may be applied topically, through microneedling, or as part of a peptide therapy program tailored to individual goals

Discovered in 1973, GHK-Cu is now recognized for its role in skincare and haircare formulations, valued for its protective and restorative properties